Bio-Rad Laboratories (BIO) Non Operating Interest Expenses (2009 - 2026)

Bio-Rad Laboratories (BIO) has reported Non Operating Interest Expenses for 18 consecutive years, with $12.1 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Non Operating Interest Expenses fell 3.97% year-over-year to $12.1 million in Q2 2026; TTM through Jun 2026 was $48.8 million, a 0.2% change from a year earlier, with the FY2025 full-year figure at $49.0 million, changed 0.2% from the prior year.
• Non Operating Interest Expenses was $12.1 million for Q2 2026 at Bio-Rad Laboratories, down from $12.3 million in the prior quarter.
• Over five years, Non Operating Interest Expenses peaked at $12.6 million in Q2 2025 and troughed at $4.0 million in Q1 2022.
• A 5-year average of $11.7 million and a median of $12.2 million in 2024 frame the typical range for Non Operating Interest Expenses.
• Across the five-year window, Non Operating Interest Expenses surged 3105.77% in 2022 and slipped 3.97% in 2026, its largest moves.
• Over 5 years, Non Operating Interest Expenses stood at $11.7 million in 2022, then climbed by 5.6% to $12.3 million in 2023, then dropped by 0.99% to $12.2 million in 2024, then decreased by 0.82% to $12.1 million in 2025, then changed by 0.0% to $12.1 million in 2026.
• The last three Non Operating Interest Expenses figures came in at $12.1 million (Q2 2026), $12.3 million (Q1 2026), and $12.1 million (Q4 2025), per Business Quant data.